Neuroimaging markers of chronic fatigue in older people: a narrative review.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 04 06 2020
accepted: 18 07 2020
pubmed: 1 8 2020
medline: 17 6 2021
entrez: 1 8 2020
Statut: ppublish

Résumé

Chronic fatigue is a common symptom in older adults. Although some studies have attempted to identify the neuronal correlates of fatigue associated with chronic diseases, the scientific evidence is scarce regarding fatigue in older people not suffering from a specific disease. To gather available evidence of neuroimaging studies investigating the associations between fatigue and brain health in older adults out of the context of a specific disease, and to identify potential brain structures associated with this symptom. Studies considering exclusively patients with a specific disease and/or studies focusing on physiological mechanisms of acute fatigue induced by the realization of cognitive and physical tasks were excluded. Very few studies on the associations of fatigue with neuroimaging markers are currently available. Fatigue was associated with reduced hippocampus volumes and with hippocampal amyloid deposition. Regarding the association between fatigue and the circuit of basal ganglia, putamen and thalamus were associated with physical fatigability, whereas amygdala and thalamus with mental fatigability. Very limited evidence about white matter integrity found that healthy individuals with high levels of fatigue had a greater total volume of leukoaraiosis. This review suggests that hippocampus damage and potentially loss of function in basal ganglia networks could play a role on chronic fatigue during aging. Further studies are needed to assess the associations of fatigue with white matter alterations.

Sections du résumé

BACKGROUND BACKGROUND
Chronic fatigue is a common symptom in older adults. Although some studies have attempted to identify the neuronal correlates of fatigue associated with chronic diseases, the scientific evidence is scarce regarding fatigue in older people not suffering from a specific disease.
AIMS OBJECTIVE
To gather available evidence of neuroimaging studies investigating the associations between fatigue and brain health in older adults out of the context of a specific disease, and to identify potential brain structures associated with this symptom.
METHODS METHODS
Studies considering exclusively patients with a specific disease and/or studies focusing on physiological mechanisms of acute fatigue induced by the realization of cognitive and physical tasks were excluded.
RESULTS RESULTS
Very few studies on the associations of fatigue with neuroimaging markers are currently available. Fatigue was associated with reduced hippocampus volumes and with hippocampal amyloid deposition. Regarding the association between fatigue and the circuit of basal ganglia, putamen and thalamus were associated with physical fatigability, whereas amygdala and thalamus with mental fatigability. Very limited evidence about white matter integrity found that healthy individuals with high levels of fatigue had a greater total volume of leukoaraiosis.
CONCLUSION CONCLUSIONS
This review suggests that hippocampus damage and potentially loss of function in basal ganglia networks could play a role on chronic fatigue during aging. Further studies are needed to assess the associations of fatigue with white matter alterations.

Identifiants

pubmed: 32734575
doi: 10.1007/s40520-020-01666-1
pii: 10.1007/s40520-020-01666-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1487-1492

Références

Zengarini E, Ruggiero C, Pérez-Zepeda MU et al (2015) Fatigue: relevance and implications in the aging population. Exp Gerontol 70:78–83
pubmed: 26190478
Aaronson LS, Teel CS, Cassmeyer V et al (1999) Defining and measuring fatigue. Image J Nurs Scholarsh 31:45–50
Hardy SE, Studenski SA (2008) Fatigue predicts mortality in older adults. J Am Geriatr Soc 56(10):1910–1914. https://doi.org/10.1111/j.1532-5415.2008.01957.x
doi: 10.1111/j.1532-5415.2008.01957.x pubmed: 18811604 pmcid: 2596279
Mänty M, de Leon CFM, Rantanen T et al (2012) Mobility-related fatigue, walking speed, and muscle strength in older people. J Gerontol A Biol Sci Med Sci 67:523–529
pubmed: 22016363
Bhalla MC, Wilber ST, Stiffler KA, et al. (2014) Weakness and fatigue in older ED patients in the United States. Am J Emerg Med 32:1395–1398.
Avlund K, Rantanen T, Schroll M (2006) Tiredness and subsequent disability in older adults: The role of walking limitations. J Gerontol A Biol Sci Med Sci 61:1201–1205
pubmed: 17167163
Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–156
pubmed: 11253156
Zengarini E, Ruggiero C, Mecocci P (2016) Fatigue as a clinical sign of biological aging: exploratory analyses from the MINDED project. Geriatr Gerontol Int 16:533–534
pubmed: 27037725
Meng H, Hale L, Friedberg F (2010) Prevalence and predictors of fatigue in middle-aged and older adults: evidence from the health and retirement study. J Am Geriatr Soc 58:2033–2034
pubmed: 20929479 pmcid: 2981161
Liao S, Ferrell BA (2000) Fatigue in an older population. J Am Geriatr Soc 48(4):426–430. https://doi.org/10.1111/j.1532-5415.2000.tb04702.x
doi: 10.1111/j.1532-5415.2000.tb04702.x pubmed: 10798471
Glynn NW, Santanasto AJ, Simonsick EM et al (2015) The Pittsburgh Fatigability scale for older adults: development and validation. J Am Geriatr Soc 63:130–135
pubmed: 25556993
Kim I, Hacker E, Ferrans CE (2018) Evaluation of fatigability measurement: Integrative review. Geriatr Nurs N Y N 39:39–47
Goñi M, Basu N, Murray AD (2018) Neural indicators of fatigue in chronic diseases: a systematic review of MRI studies. Diagn Basel Switz 21:8
Abe K, Takanashi M, Yanagihara T (2000) Fatigue in patients with Parkinson’s disease. Behav Neurol 12:103–106
pubmed: 11455047
Pavese N, Metta V, Bose SK (2010) Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction. Brain J Neurol 133:3434–3443
Chou KL, Kotagal V, Bohnen NI (2016) Neuroimaging and clinical predictors of fatigue in Parkinson disease. Parkinsonism Relat Disord 23:45–49
pubmed: 26683744
Finke C, Schlichting J, Papazoglou S et al (2015) Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue. Mult Scler Houndmills Basingstoke Engl 21:925–934
Rocca MA, Parisi L, Pagani E et al (2014) Regional but not global brain damage contributes to fatigue in multiple sclerosis. Radiology 273:511–520
pubmed: 24927473
Tang L-W, Zheng H, Chen L et al (2015) Gray matter volumes in patients with chronic fatigue syndrome. Evid-Based Complement Altern Med ECAM 2015:380615
López-Sanz D, Suárez-Méndez I, Bernabé R et al (2018) Scoping Review of Neuroimaging Studies Investigating Frailty and Frailty Components. Front Med 5:284
Wasson E, Rosso AL, Santanasto AJ et al (2019) Neural correlates of perceived physical and mental fatigability in older adults: a pilot study. Exp Gerontol 115:139–147
pubmed: 30528639
Chen W-T, Chou K-H, Liu L-K et al (2015) Reduced cerebellar gray matter is a neural signature of physical frailty. Hum Brain Mapp 36:3666–3676
pubmed: 26096356 pmcid: 6869536
Kluger BM, Zhao Q, Tanner JJ et al (2019) Structural brain correlates of fatigue in older adults with and without Parkinson’s disease. NeuroImage Clin 22:101730
pubmed: 30818269 pmcid: 6396012
Hooper C, De Souto BP, Coley N et al (2017) Cross-sectional associations of fatigue with cerebral β-amyloid in older adults at risk of dementia. Front Med 4:173
Carvalho DZ, St Louis EK, Boeve BF, Mielke MM, Przybelski SA, Knopman DS et al (2017) Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults. Sleep Med 32:236–43. https://doi.org/10.1016/j.sleep.2016.08.023
doi: 10.1016/j.sleep.2016.08.023 pubmed: 28065685
Wang Y-P, Gorenstein C (2013) Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clin Sao Paulo Braz 68:1274–1287
Krupp LB, LaRocca NG, Muir-Nash J (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 46:1121–1123
pubmed: 2803071
O’Sullivan M (2008) Leukoaraiosis. Pract Neurol 8:26–38
pubmed: 18230707
Boissoneault J, Letzen J, Lai S et al (2016) Abnormal resting state functional connectivity in patients with chronic fatigue syndrome: an arterial spin-labeling fMRI study. Magn Reson Imaging 34:603–608
pubmed: 26708036
Subramanian K, Brandenburg C, Orsati F (2017) Basal ganglia and autism - a translational perspective. Autism Res Off J Int Soc Autism Res 10:1751–1775
Durieux PF, Schiffmann SN, de Kerchove DA (2011) Targeting neuronal populations of the striatum. Front Neuroanat 5:40
pubmed: 21811438 pmcid: 3139926
Nakagawa S, Takeuchi H, Taki Y et al (2016) Basal ganglia correlates of fatigue in young adults. Sci Rep 19:21386
Bruno RL, Cohen JM, Galski T (1994) The neuroanatomy of post-polio fatigue. Arch Phys Med Rehabil 75:498–504
pubmed: 8185440
Janak PH, Tye KM (2015) From circuits to behaviour in the amygdala. Nature 517(7534):284–292. https://doi.org/10.1038/nature14188
doi: 10.1038/nature14188 pubmed: 25592533 pmcid: 4565157
Spiteri S, Hassa T, Claros-Salinas D (2019) Neural correlates of effort-dependent and effort-independent cognitive fatigue components in patients with multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 25:256–266
Basu N, Murray AD, Jones GT (2014) Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatol Oxf Engl 53:2080–2087
Griffanti L, Stratmann P, Rolinski M et al (2018) Exploring variability in basal ganglia connectivity with functional MRI in healthy aging. Brain Imaging Behav 12:1822–1827
pubmed: 29442271 pmcid: 6302142
Reeves S, Bench C, Howard R (2002) Ageing and the nigrostriatal dopaminergic system. Int J Geriatr Psychiatry 17:359–370
pubmed: 11994891
Van Dyck CH, Seibyl JP, Malison RT et al (2002) Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 10:36–43. https://doi.org/10.1097/00019442-200201000-000
doi: 10.1097/00019442-200201000-000 pubmed: 11790633
Dobryakova E, Genova HM, DeLuca J et al (2015) The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Neurol Front. https://doi.org/10.3389/fneur.2015.00052
doi: 10.3389/fneur.2015.00052
Chaudhuri A, Behan PO (2000) Fatigue and basal ganglia. J Neurol Sci 179(S 1–2):34–42. https://doi.org/10.1016/s0022-510x(00)00411-1
doi: 10.1016/s0022-510x(00)00411-1 pubmed: 11054483
Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363(9413):978–988. https://doi.org/10.1016/S0140-6736(04)15794-2
doi: 10.1016/S0140-6736(04)15794-2 pubmed: 15043967
Calabresi P, Castrioto A, Di Filippo M et al (2013) New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. Lancet Neurol 12:811–821. https://doi.org/10.1016/S1474-4422
doi: 10.1016/S1474-4422 pubmed: 23867199
Shaw ME, Sachdev PS, Anstey KJ et al (2016) Age-related cortical thinning in cognitively healthy individuals in their 60s: the PATH Through Life study. Neurobiol Aging 39:202–209
pubmed: 26923417
Storsve AB, Fjell AM, Tamnes CK et al (2014) Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: regions of accelerating and decelerating change. J Neurosci Off J Soc Neurosci 34:8488–8498
Yang Z, Wen W, Jiang J et al (2016) Age-associated differences on structural brain MRI in nondemented individuals from 71 to 103 years. Neurobiol Aging 40:86–97
pubmed: 26973107
Srikanth V, Phan TG, Chen J (2010) The location of white matter lesions and gait–a voxel-based study. Ann Neurol 67:265–269
pubmed: 20225293
Moon SY, de Souto BP, Rolland Y et al (2018) Prospective associations between white matter hyperintensities and lower extremity function. Neurology 90:e1291–e1297
pubmed: 29523640
Avila-Funes JA, Pelletier A, Meillon C et al (2017) Vascular cerebral damage in frail older adults: the AMImage study. J Gerontol A Biol Sci Med Sci 72:971–977
pubmed: 28329104
Del Brutto OH, Mera RM, Cagino K et al (2017) Neuroimaging signatures of frailty: a population-based study in community-dwelling older adults (the Atahualpa Project). Geriatr Gerontol Int 17:270–276
pubmed: 26790541
Newman AB, Gottdiener JS, Mcburnie MA et al (2001) Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 56:M158–166
pubmed: 11253157
Siejka TP, Srikanth VK, Hubbard RE et al (2018) Frailty and cerebral small vessel disease: a cross-sectional analysis of the tasmanian study of cognition and gait (TASCOG). J Gerontol A Biol Sci Med Sci 73:255–260
pubmed: 28977392
Maltais M, de Souto BP, Moon SY et al (2019) Prospective association of white matter hyperintensity volume and frailty in older adults. Exp Gerontol 118:51–54
pubmed: 30639444

Auteurs

Davide Angioni (D)

Gérontopôle of Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France. davideangioni2@gmail.com.

Kelly Virecoulon Giudici (K)

Gérontopôle of Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France.

Maria Montoya Martinez (M)

Gérontopôle of Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France.

Yves Rolland (Y)

Gérontopôle of Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France.
UPS/Inserm UMR1027, University of Toulouse III, Toulouse, France.

Bruno Vellas (B)

Gérontopôle of Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France.
UPS/Inserm UMR1027, University of Toulouse III, Toulouse, France.

Philipe de Souto Barreto (P)

Gérontopôle of Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France.
UPS/Inserm UMR1027, University of Toulouse III, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH